An all-purpose antimalarial drug target

W. Armand Guiguemde, R. Kiplin Guy

Research output: Contribution to journalShort surveypeer-review

7 Scopus citations


The recent re-emphasis on malaria eradication has made developing drugs that block transmission and terminate latent disease critical. Most drugs do not affect the liver stages - an ability that is crucial to the latter goal. Addressing this problem, Hoepfner et al. (2012) uncover the parasite's lysyl-tRNA synthetase as a druggable target.

Original languageEnglish
Pages (from-to)555-557
Number of pages3
JournalCell Host and Microbe
Issue number6
StatePublished - Jun 14 2012

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Virology


Dive into the research topics of 'An all-purpose antimalarial drug target'. Together they form a unique fingerprint.

Cite this